Literature DB >> 10217654

Mechanisms underlying aortic dilatation in congenital aortic valve malformation.

D Bonderman1, E Gharehbaghi-Schnell, G Wollenek, G Maurer, H Baumgartner, I M Lang.   

Abstract

BACKGROUND: The high incidence of aortic disease in subjects with congenital aortic valve malformations suggests a causative relationship between these 2 conditions. The histological observation in aortic dilatation/aneurysm/dissection is Erdheim cystic medial necrosis (CMN), a noninflammatory loss of smooth muscle cells (SMCs), fragmentation of elastic fibers, and mucoid degeneration. METHODS AND
RESULTS: To examine whether apoptosis is 1 of the mechanisms underlying CMN and aortic medial layer SMC loss, ascending aortic wall specimens from 32 patients were collected at cardiothoracic surgery and examined by histochemical staining and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling. From echocardiography results, 4 groups of patients were identified: bicuspid valve carriers with (bi/dil) or without (bi/0) aortic dilatation and tricuspid valve carriers with (tri/dil) or without (tri/0) aortic dilatation. Massive focal apoptosis was observed in the medial layers of bi/dil (mean apoptotic index [mAI], 8.1+/-6.0) and tri/dil (mAI, 8.1+/-8.3) compared with tri/0 (mAI, 0.9+/-1.2; P=0.0079 and P=0.037). In bi/0 (mAI, 9.1+/-5.7) compared with tri/0 (mAI, 0.9+/-1.2), rates of medial SMC apoptosis were increased (P=0.0025). Bi/dil (mean age, 40. 6+/-15.7 years) were significantly younger than tri/dil (mean age, 56.4+/-12.8 years) undergoing the same operation (P=0.0123).
CONCLUSIONS: Premature medial layer SMC apoptosis could be part of a genetic program underlying aortic disease in patients with aortic valve malformations.

Entities:  

Mesh:

Year:  1999        PMID: 10217654     DOI: 10.1161/01.cir.99.16.2138

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  52 in total

1.  Congenital coronary artery dilatation.

Authors:  S Chakrabarti; E Thomas; J G C Wright; J J Vettukattil
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

2.  Bicuspid aortic valve and coarctation: two villains part of a diffuse problem.

Authors:  C A Warnes
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

3.  New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3).

Authors:  Helena Kuivaniemi; Natzi Sakalihasan; Frank A Lederle; Gregory T Jones; Jean-Olivier Defraigne; Nicos Labropoulos; Victor Legrand; Jean-Baptiste Michel; Christoph Nienaber; Marc A Radermecker; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2013-06-01

Review 4.  Aortic regurgitation.

Authors:  Gerald Maurer
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

5.  Ascending aorta dilatation in aortic valve disease: morphological analysis of medial changes.

Authors:  Lucio Agozzino; Pasquale Santè; Franca Ferraraccio; Marina Accardo; Marisa De Feo; Luca Salvatore De Santo; Gianantonio Nappi; Manuela Agozzino; Salvatore Esposito
Journal:  Heart Vessels       Date:  2006-07       Impact factor: 2.037

6.  The genetic and molecular basis of bicuspid aortic valve associated thoracic aortopathy: a link to phenotype heterogeneity.

Authors:  Ratnasari Padang; Paul G Bannon; Richmond Jeremy; David R Richmond; Christopher Semsarian; Michael Vallely; Michael Wilson; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2013-01

7.  Late post-AVR progression of bicuspid aortopathy: link to hemodynamics.

Authors:  Shiho Naito; Tatiana Gross; Kushtrim Disha; Yskert von Kodolitsch; Hermann Reichenspurner; Evaldas Girdauskas
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-13

Review 8.  Multimodality imaging assessment of bicuspid aortic valve disease, thoracic aortic ectasia, and thoracic aortic aneurysmal disease.

Authors:  Preethi Mani; Reza Reyaldeen; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 9.  A measured approach to managing the aortic root in patients with bicuspid aortic valve disease.

Authors:  Ismail El-Hamamsy; Magdi H Yacoub
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

10.  Hemodynamic predictors of aortic dilatation in bicuspid aortic valve by velocity-encoded cardiovascular magnetic resonance.

Authors:  P Martijn den Reijer; Denver Sallee; Petra van der Velden; Eline R Zaaijer; W James Parks; Senthil Ramamurthy; Trevor Q Robbie; Giorgina Donati; Carey Lamphier; Rudolf P Beekman; Marijn E Brummer
Journal:  J Cardiovasc Magn Reson       Date:  2010-01-13       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.